Exome Asset Management LLC Procaps Group, S.A. Transaction History

Exome Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Dec 13, 2024	BUY	$1.71 - $2.61 $217,000 - $331,211	126,901 New	126,901 $280 Million
Q2 2024 Oct 03, 2024	SELL	$2.51 - $2.97 $6,023 - $7,128	-2,400 Reduced 1.86%	126,901 $321 Million
Q2 2024 Aug 14, 2024	BUY	$2.51 - $2.97 $324,545 - $384,023	129,301 New	129,301 $877 Million
Q4 2023 Feb 14, 2024	BUY	$2.18 - $4.14 $276,644 - $525,370	126,901 New	126,901 $516 Million

53.3K

Ticker PROC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 112,824,000
Market Cap $193M
Description
Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and ...

Get notified when there are updates to the investment portfolio of Exome Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Exome Asset Management LLC with notifications on news.